Results 121 to 130 of about 18,542 (210)

Network meta-analysis of the efficacy of pharmacological treatments for post-stroke cognitive impairment and vascular cognitive impairment. [PDF]

Front Neurol
Li W, Liu X, Gao C, Li W, Liao X.
europepmc   +1 more source

Natural Chiral Scaffolds in Alzheimer's Disease: Therapeutic Potential, Mechanism, and Clinical Aspects. [PDF]

Biomed Res Int
Singh A, Sahu SK, Sah AK.
europepmc   +1 more source

The role of genetic polymorphisms on drug response in Alzheimer's disease: a systematic review. [PDF]

BMC Med Genomics
Climacosa FMM, Ornos EDB, Gapaz NCLL, Guantia MGR, Cruz JMC, Manalo RVM, Yu ML, Qureshi AP, Carampel AC, Asis JLB, Reyes JCB, Dacasin AB, Anlacan VMM.   +12 more
europepmc   +1 more source

SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine: A Pilot Multicenter Randomized Placebo-Controlled Trial. [PDF]

Neurocrit Care
Yang BSK, Savarraj JPJ, Moreno E, Immanuel KE, Hergenroeder G, Torres G, Kim JH, Samuel S, Pedroza C, Grotta JC, Barreto A, Choi HA.   +11 more
europepmc   +1 more source

A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer's drug repurposing. [PDF]

Sci Rep
Gider V, Budak C.
europepmc   +1 more source

Intranasal administration of acetylcholinesterase inhibitors [PDF]

Henry R Costantino, Alexis Kays Leonard, Gordon Brandt, Paul H Johnson, Steven C Quay, HR Costantino, Y Wang, HS Chow, HH Chow, XF Liu, QZ Zhang, U Westin, UE Westin, D Wang, M Dahlin, MP Van den Berg, MP van den Berg, MP van den Berg, Z Yang, T Sakane, T Sakane, T Sakane, L Illum, JC Olivier, S Ahmed, MA Hussain, AK Leonard, AK Leonard, CG Ballard, HW Klafki, DS Geldmacher, RJ Caselli, ML Crismon, M Samochocki, G Lou, AV Gore, K Walter, JJ Sramek, VI Turiiski, PH Johnson, M Yamashita   +40 more
core   +1 more source

Orodispersible Hydrogel Film Technology for Optimized Galantamine Delivery in the Treatment of Alzheimer's Disease. [PDF]

Gels
Georgieva D, Bogdanova I, Mihaylova R, Alexandrova M, Bozhilova S, Christova D, Kostova B.   +6 more
europepmc   +1 more source

Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials. [PDF]

Syst Rev
Abouelmagd ME, Almosilhy NA, Makhlouf HA, Hassan AK, Osman ASA, Hindawi MD, Elshahat A, Alnajjar AZ, Mustafa MMM, Abdelsalam OK, Mady A, Shaheen A, Barrett MJ, Negida A.   +13 more
europepmc   +1 more source

Rapid health technology assessment of galantamine for the treatment of Alzheimer's disease: A review. [PDF]

Medicine (Baltimore)
Xing B, Yang J, Hua H, Jiang R.
europepmc   +1 more source

Current pharmacologic options for patients with Alzheimer's disease [PDF]

William E Reichman
core   +1 more source